The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Vial and Prefilled Syringe-Global Market Insights and Sales Trends 2025

Vial and Prefilled Syringe-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1829237

No of Pages : 111

Synopsis
The global Vial and Prefilled Syringe market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Vial and Prefilled Syringe in various end use industries. The expanding demands from the Antithrombotics, Vaccines, Autoimmune Diseases and Anti-inflammatory Drugs, are propelling Vial and Prefilled Syringe market. Glass Vial and Prefilled Syringe, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Polymer Vial and Prefilled Syringe segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Vial and Prefilled Syringe market, driven by demand from China, the second largest economy with some signs of stabilising, the Vial and Prefilled Syringe market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Vial and Prefilled Syringe, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Vial and Prefilled Syringe market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Vial and Prefilled Syringe market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Vial and Prefilled Syringe sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Vial and Prefilled Syringe covered in this report include BD (US), Gerresheimer (DE), Nipro Corporation (JP), Schott forma vitrum (DE), Ompi (IT), Baxter BioPharma Solution (US), ROVI CM (ES), Terumo (JP) and Vetter (DE), etc.
The global Vial and Prefilled Syringe market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
BD (US)
Gerresheimer (DE)
Nipro Corporation (JP)
Schott forma vitrum (DE)
Ompi (IT)
Baxter BioPharma Solution (US)
ROVI CM (ES)
Terumo (JP)
Vetter (DE)
Unilife Corporation (US)
Taisei Kako (JP)
Roselabs Group (IN)
ARTE CORPORATION (JP)
Weigao Group Medical Polymer (CN)
Zibo Minkang Pharmaceutical (CN)
Shandong Pharmaceutical Glass (CN)
Global Vial and Prefilled Syringe market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Vial and Prefilled Syringe market, Segment by Type:
Glass Vial and Prefilled Syringe
Polymer Vial and Prefilled Syringe
Global Vial and Prefilled Syringe market, by Application
Antithrombotics
Vaccines
Autoimmune Diseases
Anti-inflammatory Drugs
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Vial and Prefilled Syringe manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Vial and Prefilled Syringe in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Vial and Prefilled Syringe Market Overview
1.1 Vial and Prefilled Syringe Product Overview
1.2 Vial and Prefilled Syringe Market Segment by Type
1.2.1 Glass Vial and Prefilled Syringe
1.2.2 Polymer Vial and Prefilled Syringe
1.3 Global Vial and Prefilled Syringe Market Size by Type
1.3.1 Global Vial and Prefilled Syringe Market Size Overview by Type (2018-2029)
1.3.2 Global Vial and Prefilled Syringe Historic Market Size Review by Type (2018-2023)
1.3.3 Global Vial and Prefilled Syringe Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Vial and Prefilled Syringe Sales Breakdown by Type (2018-2023)
1.4.2 Europe Vial and Prefilled Syringe Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Vial and Prefilled Syringe Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Vial and Prefilled Syringe Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Vial and Prefilled Syringe Sales Breakdown by Type (2018-2023)
2 Global Vial and Prefilled Syringe Market Competition by Company
2.1 Global Top Players by Vial and Prefilled Syringe Sales (2018-2023)
2.2 Global Top Players by Vial and Prefilled Syringe Revenue (2018-2023)
2.3 Global Top Players by Vial and Prefilled Syringe Price (2018-2023)
2.4 Global Top Manufacturers Vial and Prefilled Syringe Manufacturing Base Distribution, Sales Area, Product Type
2.5 Vial and Prefilled Syringe Market Competitive Situation and Trends
2.5.1 Vial and Prefilled Syringe Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Vial and Prefilled Syringe Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Vial and Prefilled Syringe as of 2022)
2.7 Date of Key Manufacturers Enter into Vial and Prefilled Syringe Market
2.8 Key Manufacturers Vial and Prefilled Syringe Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Vial and Prefilled Syringe Status and Outlook by Region
3.1 Global Vial and Prefilled Syringe Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Vial and Prefilled Syringe Historic Market Size by Region
3.2.1 Global Vial and Prefilled Syringe Sales in Volume by Region (2018-2023)
3.2.2 Global Vial and Prefilled Syringe Sales in Value by Region (2018-2023)
3.2.3 Global Vial and Prefilled Syringe Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Vial and Prefilled Syringe Forecasted Market Size by Region
3.3.1 Global Vial and Prefilled Syringe Sales in Volume by Region (2024-2029)
3.3.2 Global Vial and Prefilled Syringe Sales in Value by Region (2024-2029)
3.3.3 Global Vial and Prefilled Syringe Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Vial and Prefilled Syringe by Application
4.1 Vial and Prefilled Syringe Market Segment by Application
4.1.1 Antithrombotics
4.1.2 Vaccines
4.1.3 Autoimmune Diseases
4.1.4 Anti-inflammatory Drugs
4.1.5 Others
4.2 Global Vial and Prefilled Syringe Market Size by Application
4.2.1 Global Vial and Prefilled Syringe Market Size Overview by Application (2018-2029)
4.2.2 Global Vial and Prefilled Syringe Historic Market Size Review by Application (2018-2023)
4.2.3 Global Vial and Prefilled Syringe Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Vial and Prefilled Syringe Sales Breakdown by Application (2018-2023)
4.3.2 Europe Vial and Prefilled Syringe Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Vial and Prefilled Syringe Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Vial and Prefilled Syringe Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Vial and Prefilled Syringe Sales Breakdown by Application (2018-2023)
5 North America Vial and Prefilled Syringe by Country
5.1 North America Vial and Prefilled Syringe Historic Market Size by Country
5.1.1 North America Vial and Prefilled Syringe Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Vial and Prefilled Syringe Sales in Volume by Country (2018-2023)
5.1.3 North America Vial and Prefilled Syringe Sales in Value by Country (2018-2023)
5.2 North America Vial and Prefilled Syringe Forecasted Market Size by Country
5.2.1 North America Vial and Prefilled Syringe Sales in Volume by Country (2024-2029)
5.2.2 North America Vial and Prefilled Syringe Sales in Value by Country (2024-2029)
6 Europe Vial and Prefilled Syringe by Country
6.1 Europe Vial and Prefilled Syringe Historic Market Size by Country
6.1.1 Europe Vial and Prefilled Syringe Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Vial and Prefilled Syringe Sales in Volume by Country (2018-2023)
6.1.3 Europe Vial and Prefilled Syringe Sales in Value by Country (2018-2023)
6.2 Europe Vial and Prefilled Syringe Forecasted Market Size by Country
6.2.1 Europe Vial and Prefilled Syringe Sales in Volume by Country (2024-2029)
6.2.2 Europe Vial and Prefilled Syringe Sales in Value by Country (2024-2029)
7 Asia-Pacific Vial and Prefilled Syringe by Region
7.1 Asia-Pacific Vial and Prefilled Syringe Historic Market Size by Region
7.1.1 Asia-Pacific Vial and Prefilled Syringe Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Vial and Prefilled Syringe Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Vial and Prefilled Syringe Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Vial and Prefilled Syringe Forecasted Market Size by Region
7.2.1 Asia-Pacific Vial and Prefilled Syringe Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Vial and Prefilled Syringe Sales in Value by Region (2024-2029)
8 Latin America Vial and Prefilled Syringe by Country
8.1 Latin America Vial and Prefilled Syringe Historic Market Size by Country
8.1.1 Latin America Vial and Prefilled Syringe Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Vial and Prefilled Syringe Sales in Volume by Country (2018-2023)
8.1.3 Latin America Vial and Prefilled Syringe Sales in Value by Country (2018-2023)
8.2 Latin America Vial and Prefilled Syringe Forecasted Market Size by Country
8.2.1 Latin America Vial and Prefilled Syringe Sales in Volume by Country (2024-2029)
8.2.2 Latin America Vial and Prefilled Syringe Sales in Value by Country (2024-2029)
9 Middle East and Africa Vial and Prefilled Syringe by Country
9.1 Middle East and Africa Vial and Prefilled Syringe Historic Market Size by Country
9.1.1 Middle East and Africa Vial and Prefilled Syringe Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Vial and Prefilled Syringe Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Vial and Prefilled Syringe Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Vial and Prefilled Syringe Forecasted Market Size by Country
9.2.1 Middle East and Africa Vial and Prefilled Syringe Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Vial and Prefilled Syringe Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 BD (US)
10.1.1 BD (US) Company Information
10.1.2 BD (US) Introduction and Business Overview
10.1.3 BD (US) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2018-2023)
10.1.4 BD (US) Vial and Prefilled Syringe Products Offered
10.1.5 BD (US) Recent Development
10.2 Gerresheimer (DE)
10.2.1 Gerresheimer (DE) Company Information
10.2.2 Gerresheimer (DE) Introduction and Business Overview
10.2.3 Gerresheimer (DE) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Gerresheimer (DE) Vial and Prefilled Syringe Products Offered
10.2.5 Gerresheimer (DE) Recent Development
10.3 Nipro Corporation (JP)
10.3.1 Nipro Corporation (JP) Company Information
10.3.2 Nipro Corporation (JP) Introduction and Business Overview
10.3.3 Nipro Corporation (JP) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Nipro Corporation (JP) Vial and Prefilled Syringe Products Offered
10.3.5 Nipro Corporation (JP) Recent Development
10.4 Schott forma vitrum (DE)
10.4.1 Schott forma vitrum (DE) Company Information
10.4.2 Schott forma vitrum (DE) Introduction and Business Overview
10.4.3 Schott forma vitrum (DE) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Schott forma vitrum (DE) Vial and Prefilled Syringe Products Offered
10.4.5 Schott forma vitrum (DE) Recent Development
10.5 Ompi (IT)
10.5.1 Ompi (IT) Company Information
10.5.2 Ompi (IT) Introduction and Business Overview
10.5.3 Ompi (IT) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Ompi (IT) Vial and Prefilled Syringe Products Offered
10.5.5 Ompi (IT) Recent Development
10.6 Baxter BioPharma Solution (US)
10.6.1 Baxter BioPharma Solution (US) Company Information
10.6.2 Baxter BioPharma Solution (US) Introduction and Business Overview
10.6.3 Baxter BioPharma Solution (US) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Baxter BioPharma Solution (US) Vial and Prefilled Syringe Products Offered
10.6.5 Baxter BioPharma Solution (US) Recent Development
10.7 ROVI CM (ES)
10.7.1 ROVI CM (ES) Company Information
10.7.2 ROVI CM (ES) Introduction and Business Overview
10.7.3 ROVI CM (ES) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2018-2023)
10.7.4 ROVI CM (ES) Vial and Prefilled Syringe Products Offered
10.7.5 ROVI CM (ES) Recent Development
10.8 Terumo (JP)
10.8.1 Terumo (JP) Company Information
10.8.2 Terumo (JP) Introduction and Business Overview
10.8.3 Terumo (JP) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Terumo (JP) Vial and Prefilled Syringe Products Offered
10.8.5 Terumo (JP) Recent Development
10.9 Vetter (DE)
10.9.1 Vetter (DE) Company Information
10.9.2 Vetter (DE) Introduction and Business Overview
10.9.3 Vetter (DE) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Vetter (DE) Vial and Prefilled Syringe Products Offered
10.9.5 Vetter (DE) Recent Development
10.10 Unilife Corporation (US)
10.10.1 Unilife Corporation (US) Company Information
10.10.2 Unilife Corporation (US) Introduction and Business Overview
10.10.3 Unilife Corporation (US) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Unilife Corporation (US) Vial and Prefilled Syringe Products Offered
10.10.5 Unilife Corporation (US) Recent Development
10.11 Taisei Kako (JP)
10.11.1 Taisei Kako (JP) Company Information
10.11.2 Taisei Kako (JP) Introduction and Business Overview
10.11.3 Taisei Kako (JP) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Taisei Kako (JP) Vial and Prefilled Syringe Products Offered
10.11.5 Taisei Kako (JP) Recent Development
10.12 Roselabs Group (IN)
10.12.1 Roselabs Group (IN) Company Information
10.12.2 Roselabs Group (IN) Introduction and Business Overview
10.12.3 Roselabs Group (IN) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Roselabs Group (IN) Vial and Prefilled Syringe Products Offered
10.12.5 Roselabs Group (IN) Recent Development
10.13 ARTE CORPORATION (JP)
10.13.1 ARTE CORPORATION (JP) Company Information
10.13.2 ARTE CORPORATION (JP) Introduction and Business Overview
10.13.3 ARTE CORPORATION (JP) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2018-2023)
10.13.4 ARTE CORPORATION (JP) Vial and Prefilled Syringe Products Offered
10.13.5 ARTE CORPORATION (JP) Recent Development
10.14 Weigao Group Medical Polymer (CN)
10.14.1 Weigao Group Medical Polymer (CN) Company Information
10.14.2 Weigao Group Medical Polymer (CN) Introduction and Business Overview
10.14.3 Weigao Group Medical Polymer (CN) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Weigao Group Medical Polymer (CN) Vial and Prefilled Syringe Products Offered
10.14.5 Weigao Group Medical Polymer (CN) Recent Development
10.15 Zibo Minkang Pharmaceutical (CN)
10.15.1 Zibo Minkang Pharmaceutical (CN) Company Information
10.15.2 Zibo Minkang Pharmaceutical (CN) Introduction and Business Overview
10.15.3 Zibo Minkang Pharmaceutical (CN) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Zibo Minkang Pharmaceutical (CN) Vial and Prefilled Syringe Products Offered
10.15.5 Zibo Minkang Pharmaceutical (CN) Recent Development
10.16 Shandong Pharmaceutical Glass (CN)
10.16.1 Shandong Pharmaceutical Glass (CN) Company Information
10.16.2 Shandong Pharmaceutical Glass (CN) Introduction and Business Overview
10.16.3 Shandong Pharmaceutical Glass (CN) Vial and Prefilled Syringe Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Shandong Pharmaceutical Glass (CN) Vial and Prefilled Syringe Products Offered
10.16.5 Shandong Pharmaceutical Glass (CN) Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Vial and Prefilled Syringe Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Vial and Prefilled Syringe Industrial Chain Analysis
11.4 Vial and Prefilled Syringe Market Dynamics
11.4.1 Vial and Prefilled Syringe Industry Trends
11.4.2 Vial and Prefilled Syringe Market Drivers
11.4.3 Vial and Prefilled Syringe Market Challenges
11.4.4 Vial and Prefilled Syringe Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Vial and Prefilled Syringe Distributors
12.3 Vial and Prefilled Syringe Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’